Shire plc (NASDAQ: SHPG) Stock Competitors & Peer Comparison
See SHPG's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for SHPG and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SHPG | $179.20 | +0.00% | 0 | 11.35 | $15.79 | +0.59% |
| RPRX | $61.41 | +0.92% | 27.2B | 11.70 | $5.25 | +1.50% |
| CORT | $113.35 | -0.47% | 12.3B | 323.86 | $0.35 | N/A |
| WBA | $11.98 | +0.50% | 10.4B | -1.64 | -$7.29 | +4.17% |
| LQDA | $68.17 | +0.71% | 6.1B | 486.93 | $0.14 | N/A |
| KNSA | $78.63 | +0.70% | 6B | 87.37 | $0.90 | N/A |
| PBH | $51.78 | -1.32% | 2.5B | 11.71 | $4.42 | N/A |
| HROWL | $25.61 | +0.19% | 1.4B | N/A | N/A | N/A |
| HROWM | $26.03 | -0.08% | 1.3B | N/A | N/A | N/A |
| LTGO | $22.02 | -9.12% | 1.3B | N/A | N/A | N/A |
Stock Comparison
Royalty Pharma plc (NASDAQ: RPRX)
SHPG vs RPRX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, RPRX has a market cap of 27.2B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while RPRX trades at $61.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas RPRX's P/E ratio is 11.70. In terms of profitability, SHPG's ROE is +0.13%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, SHPG is less volatile compared to RPRX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check RPRX's competition here
Corcept Therapeutics Incorporated (NASDAQ: CORT)
SHPG vs CORT Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CORT has a market cap of 12.3B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CORT trades at $113.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CORT's P/E ratio is 323.86. In terms of profitability, SHPG's ROE is +0.13%, compared to CORT's ROE of +0.08%. Regarding short-term risk, SHPG is less volatile compared to CORT. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CORT's competition here
Walgreens Boots Alliance, Inc. (NASDAQ: WBA)
SHPG vs WBA Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, WBA has a market cap of 10.4B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while WBA trades at $11.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas WBA's P/E ratio is -1.64. In terms of profitability, SHPG's ROE is +0.13%, compared to WBA's ROE of -0.42%. Regarding short-term risk, SHPG is similarly volatile compared to WBA. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check WBA's competition here
Liquidia Corporation (NASDAQ: LQDA)
SHPG vs LQDA Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LQDA has a market cap of 6.1B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LQDA trades at $68.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LQDA's P/E ratio is 486.93. In terms of profitability, SHPG's ROE is +0.13%, compared to LQDA's ROE of +1.50%. Regarding short-term risk, SHPG is less volatile compared to LQDA. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check LQDA's competition here
Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA)
SHPG vs KNSA Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, KNSA has a market cap of 6B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while KNSA trades at $78.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas KNSA's P/E ratio is 87.37. In terms of profitability, SHPG's ROE is +0.13%, compared to KNSA's ROE of +0.14%. Regarding short-term risk, SHPG is less volatile compared to KNSA. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check KNSA's competition here
Prestige Consumer Healthcare Inc. (NYSE: PBH)
SHPG vs PBH Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, PBH has a market cap of 2.5B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while PBH trades at $51.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas PBH's P/E ratio is 11.71. In terms of profitability, SHPG's ROE is +0.13%, compared to PBH's ROE of +0.09%. Regarding short-term risk, SHPG is less volatile compared to PBH. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check PBH's competition here
Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ: HROWL)
SHPG vs HROWL Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HROWL has a market cap of 1.4B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HROWL trades at $25.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HROWL's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to HROWL's ROE of -1.04%. Regarding short-term risk, SHPG is less volatile compared to HROWL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HROWL's competition here
Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ: HROWM)
SHPG vs HROWM Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HROWM has a market cap of 1.3B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HROWM trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HROWM's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to HROWM's ROE of -1.04%. Regarding short-term risk, SHPG is less volatile compared to HROWM. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HROWM's competition here
Latigo Biotherapeutics Inc. (NASDAQ: LTGO)
SHPG vs LTGO Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LTGO has a market cap of 1.3B. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LTGO trades at $22.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LTGO's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to LTGO's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to LTGO. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check LTGO's competition here
Cybin Inc. Common Stock (NASDAQ: HELP)
SHPG vs HELP Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HELP has a market cap of 728.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HELP trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HELP's P/E ratio is -2.82. In terms of profitability, SHPG's ROE is +0.13%, compared to HELP's ROE of -0.71%. Regarding short-term risk, SHPG is less volatile compared to HELP. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HELP's competition here
Sinovac Biotech Ltd. (NASDAQ: SVA)
SHPG vs SVA Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SVA has a market cap of 464.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SVA trades at $6.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SVA's P/E ratio is -5.68. In terms of profitability, SHPG's ROE is +0.13%, compared to SVA's ROE of -0.01%. Regarding short-term risk, SHPG is similarly volatile compared to SVA. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check SVA's competition here
Clinuvel Pharmaceuticals Ltd. (NASDAQ: CUVL)
SHPG vs CUVL Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CUVL has a market cap of 300M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CUVL trades at $5.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CUVL's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to CUVL's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to CUVL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CUVL's competition here
Bristol-Myers Squibb Company Ce (NYSE: CELG-RI)
SHPG vs CELG-RI Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CELG-RI has a market cap of 244.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CELG-RI trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CELG-RI's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to CELG-RI's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to CELG-RI. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CELG-RI's competition here
High Tide Inc. (NASDAQ: HITI)
SHPG vs HITI Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, HITI has a market cap of 220.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while HITI trades at $2.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas HITI's P/E ratio is -7.36. In terms of profitability, SHPG's ROE is +0.13%, compared to HITI's ROE of -0.43%. Regarding short-term risk, SHPG is less volatile compared to HITI. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check HITI's competition here
Atlantic International Corp. (NASDAQ: ATLN)
SHPG vs ATLN Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, ATLN has a market cap of 73.2M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while ATLN trades at $0.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas ATLN's P/E ratio is -0.68. In terms of profitability, SHPG's ROE is +0.13%, compared to ATLN's ROE of -83.20%. Regarding short-term risk, SHPG is less volatile compared to ATLN. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check ATLN's competition here
Citius Oncology, Inc. (NASDAQ: CTOR)
SHPG vs CTOR Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CTOR has a market cap of 71.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CTOR trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CTOR's P/E ratio is -1.64. In terms of profitability, SHPG's ROE is +0.13%, compared to CTOR's ROE of -1.03%. Regarding short-term risk, SHPG is less volatile compared to CTOR. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CTOR's competition here
Stablecoin Development Corp. (AMEX: SDEV)
SHPG vs SDEV Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SDEV has a market cap of 47.3M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SDEV trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SDEV's P/E ratio is -0.16. In terms of profitability, SHPG's ROE is +0.13%, compared to SDEV's ROE of +7.90%. Regarding short-term risk, SHPG is less volatile compared to SDEV. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SDEV's competition here
Rite Aid Corporation (NYSE: RAD)
SHPG vs RAD Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, RAD has a market cap of 36.8M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while RAD trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas RAD's P/E ratio is -0.05. In terms of profitability, SHPG's ROE is +0.13%, compared to RAD's ROE of +2.76%. Regarding short-term risk, SHPG is less volatile compared to RAD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check RAD's competition here
Nasus Pharma Ltd. (AMEX: NSRX)
SHPG vs NSRX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, NSRX has a market cap of 35.2M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while NSRX trades at $4.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas NSRX's P/E ratio is -5.67. In terms of profitability, SHPG's ROE is +0.13%, compared to NSRX's ROE of -1.59%. Regarding short-term risk, SHPG is less volatile compared to NSRX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check NSRX's competition here
Damora Therapeutics, Inc. (NASDAQ: GLTO)
SHPG vs GLTO Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, GLTO has a market cap of 34.5M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while GLTO trades at $21.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas GLTO's P/E ratio is -1.78. In terms of profitability, SHPG's ROE is +0.13%, compared to GLTO's ROE of -0.83%. Regarding short-term risk, SHPG is less volatile compared to GLTO. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check GLTO's competition here
SCYNEXIS, Inc. (NASDAQ: SCYX)
SHPG vs SCYX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SCYX has a market cap of 32.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SCYX trades at $5.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SCYX's P/E ratio is -1.53. In terms of profitability, SHPG's ROE is +0.13%, compared to SCYX's ROE of -0.21%. Regarding short-term risk, SHPG is less volatile compared to SCYX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SCYX's competition here
Biofrontera Inc. (NASDAQ: BFRI)
SHPG vs BFRI Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BFRI has a market cap of 19.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BFRI trades at $1.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BFRI's P/E ratio is -2.78. In terms of profitability, SHPG's ROE is +0.13%, compared to BFRI's ROE of -1.28%. Regarding short-term risk, SHPG is less volatile compared to BFRI. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BFRI's competition here
Cerenome, Inc. (NASDAQ: CNSY)
SHPG vs CNSY Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CNSY has a market cap of 19.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CNSY trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CNSY's P/E ratio is -0.39. In terms of profitability, SHPG's ROE is +0.13%, compared to CNSY's ROE of -3.94%. Regarding short-term risk, SHPG is less volatile compared to CNSY. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CNSY's competition here
Scienture Holdings, Inc. (NASDAQ: SCNX)
SHPG vs SCNX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SCNX has a market cap of 15.8M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SCNX trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SCNX's P/E ratio is -0.15. In terms of profitability, SHPG's ROE is +0.13%, compared to SCNX's ROE of -0.00%. Regarding short-term risk, SHPG is less volatile compared to SCNX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SCNX's competition here
Biofrontera Inc. (NASDAQ: BFRIW)
SHPG vs BFRIW Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BFRIW has a market cap of 14.7M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BFRIW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BFRIW's P/E ratio is -0.02. In terms of profitability, SHPG's ROE is +0.13%, compared to BFRIW's ROE of -1.28%. Regarding short-term risk, SHPG is similarly volatile compared to BFRIW. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check BFRIW's competition here
Cosmos Health Inc. (NASDAQ: COSM)
SHPG vs COSM Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, COSM has a market cap of 13.2M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while COSM trades at $0.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas COSM's P/E ratio is -0.33. In terms of profitability, SHPG's ROE is +0.13%, compared to COSM's ROE of -1.19%. Regarding short-term risk, SHPG is less volatile compared to COSM. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check COSM's competition here
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD)
SHPG vs CJJD Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CJJD has a market cap of 9.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CJJD trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CJJD's P/E ratio is -0.46. In terms of profitability, SHPG's ROE is +0.13%, compared to CJJD's ROE of -0.25%. Regarding short-term risk, SHPG is less volatile compared to CJJD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CJJD's competition here
SunLink Health Systems, Inc. (AMEX: SSY)
SHPG vs SSY Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, SSY has a market cap of 7.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while SSY trades at $1.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas SSY's P/E ratio is -2.86. In terms of profitability, SHPG's ROE is +0.13%, compared to SSY's ROE of -0.09%. Regarding short-term risk, SHPG is less volatile compared to SSY. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check SSY's competition here
POMDOCTOR Ltd (NASDAQ: POM)
SHPG vs POM Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, POM has a market cap of 6.5M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while POM trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas POM's P/E ratio is -0.19. In terms of profitability, SHPG's ROE is +0.13%, compared to POM's ROE of +0.16%. Regarding short-term risk, SHPG is less volatile compared to POM. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check POM's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMS)
SHPG vs BGMS Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BGMS has a market cap of 4.8M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BGMS trades at $0.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BGMS's P/E ratio is -0.24. In terms of profitability, SHPG's ROE is +0.13%, compared to BGMS's ROE of -0.32%. Regarding short-term risk, SHPG is less volatile compared to BGMS. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BGMS's competition here
Paranovus Entertainment Technology Ltd. (NASDAQ: PAVS)
SHPG vs PAVS Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, PAVS has a market cap of 4.5M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while PAVS trades at $5.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas PAVS's P/E ratio is -0.06. In terms of profitability, SHPG's ROE is +0.13%, compared to PAVS's ROE of -0.46%. Regarding short-term risk, SHPG is less volatile compared to PAVS. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check PAVS's competition here
MedAvail Holdings, Inc. (NASDAQ: MDVL)
SHPG vs MDVL Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, MDVL has a market cap of 2.9M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while MDVL trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas MDVL's P/E ratio is -0.05. In terms of profitability, SHPG's ROE is +0.13%, compared to MDVL's ROE of -2.39%. Regarding short-term risk, SHPG is less volatile compared to MDVL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check MDVL's competition here
ETHZilla Corporation Warrant (NASDAQ: ATNFW)
SHPG vs ATNFW Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, ATNFW has a market cap of 2.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while ATNFW trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas ATNFW's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to ATNFW's ROE of -2.15%. Regarding short-term risk, SHPG is less volatile compared to ATNFW. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check ATNFW's competition here
Bio Green Med Solution, Inc. (NASDAQ: BGMSP)
SHPG vs BGMSP Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, BGMSP has a market cap of 2.4M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while BGMSP trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas BGMSP's P/E ratio is -0.84. In terms of profitability, SHPG's ROE is +0.13%, compared to BGMSP's ROE of -0.32%. Regarding short-term risk, SHPG is less volatile compared to BGMSP. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check BGMSP's competition here
AstraZeneca PLC ADRhedged (AMEX: AZNH)
SHPG vs AZNH Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, AZNH has a market cap of 1.6M. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while AZNH trades at $53.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas AZNH's P/E ratio is 38.35. In terms of profitability, SHPG's ROE is +0.13%, compared to AZNH's ROE of +0.00%. Regarding short-term risk, SHPG is less volatile compared to AZNH. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check AZNH's competition here
Leafly Holdings, Inc. (NASDAQ: LFLYW)
SHPG vs LFLYW Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, LFLYW has a market cap of 299.9K. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while LFLYW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas LFLYW's P/E ratio is -0.00. In terms of profitability, SHPG's ROE is +0.13%, compared to LFLYW's ROE of +0.42%. Regarding short-term risk, SHPG is similarly volatile compared to LFLYW. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check LFLYW's competition here
ProPhase Labs, Inc. (NASDAQ: PRPH)
SHPG vs PRPH Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, PRPH has a market cap of 294.3K. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while PRPH trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas PRPH's P/E ratio is -0.01. In terms of profitability, SHPG's ROE is +0.13%, compared to PRPH's ROE of -13.59%. Regarding short-term risk, SHPG is less volatile compared to PRPH. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check PRPH's competition here
Orexigen Therapeutics, Inc. (NASDAQ: OREX)
SHPG vs OREX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, OREX has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while OREX trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas OREX's P/E ratio is -0.14. In terms of profitability, SHPG's ROE is +0.13%, compared to OREX's ROE of -0.54%. Regarding short-term risk, SHPG is less volatile compared to OREX. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check OREX's competition here
Caraco Pharmaceutical Laboratories Ltd (AMEX: CPD)
SHPG vs CPD Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, CPD has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while CPD trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas CPD's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to CPD's ROE of N/A. Regarding short-term risk, SHPG is less volatile compared to CPD. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check CPD's competition here
Express Scripts Holding Company (NASDAQ: ESRX)
SHPG vs ESRX Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, ESRX has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while ESRX trades at $92.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas ESRX's P/E ratio is 10.69. In terms of profitability, SHPG's ROE is +0.13%, compared to ESRX's ROE of +0.26%. Regarding short-term risk, SHPG is similarly volatile compared to ESRX. This indicates similar risk in terms of short-term price fluctuations for SHPG.Check ESRX's competition here
Impax Laboratories, Inc. (NASDAQ: IPXL)
SHPG vs IPXL Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, IPXL has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while IPXL trades at $18.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas IPXL's P/E ratio is -10.11. In terms of profitability, SHPG's ROE is +0.13%, compared to IPXL's ROE of -1.16%. Regarding short-term risk, SHPG is less volatile compared to IPXL. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check IPXL's competition here
POZEN Inc. (NASDAQ: POZN)
SHPG vs POZN Comparison September 2026
Shire plc (NASDAQ: SHPG) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SHPG stands at 0. In comparison, POZN has a market cap of 0. Regarding current trading prices, SHPG is priced at $179.20 on the NASDAQ, while POZN trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SHPG currently has a P/E ratio of 11.35, whereas POZN's P/E ratio is N/A. In terms of profitability, SHPG's ROE is +0.13%, compared to POZN's ROE of +0.61%. Regarding short-term risk, SHPG is less volatile compared to POZN. This indicates lower risk in terms of short-term price fluctuations for SHPG.Check POZN's competition here